Bausch and Lomb Zyoptix 217z100 Laser

The B+ L Zyoptix 217z100 laser suite

The B+L Zyoptix 217z100 excimer laser is the leading flying spot laser on the market. Flying spot technology permits treatment of large regions of the cornea with extreme precision and accuracy. The B+L 217z100 excimer laser is also capable of treating very large diameter areas of the cornea, blending the transition between treated and non-treated cornea very smoothly. This helps increase the quality of vision and reduce the risk of glare and halos after treatment. In FDA clinical trials, the B+L Zyoptix 217z100 excimer laser has produced results that greatly exceeded FDA’s benchmarks for clinical safety as well as the clinical outcomes of other lasers on the market.

The FDA clinical trials and most other Technolas 217 lasers in use are the earlier “a” version. Our more advanced Zyoptix 217z100 is equipped with an infrared video eye tracking system that adjusts the treatment beam for any small eye movements you make during surgery. The laser's tracker locks onto the position of the center of your pupil before treatment begins and looks to see where the eye is pointed 120 times per second. In about 10 milliseconds, the aiming mirrors of the laser can re-position the treatment beam to keep it on target. If your eye moves too much, the tracker will pause the treatment laser until Dr. MacRae has you re-aligned. Our laser is also upgraded with the newest 100 hertz technology. The laser places 100 treatment spots on the cornea every second making treatment times shorter which can increase its accuracy when compared to the older 50 hertz version.

Our B+L Zyoptix 217z100 was one of the first in the country enabled to perform Customized Ablation treatment of the eye’s higher order optical aberrations using the Zyoptix Personalized Vision Correction system. In fact, the basic concept behind Zyoptix, wavefront sensing, was developed at the University of Rochester’s Center for Visual Science and developed clinically at StrongVision by Dr. MacRae.

Did You Know… The Alliance for Vision Excellence is a collaboration between: StrongVision-University of Rochester Dept of Ophthalmology University of Rochester Center for Visual Science Bausch and Lomb This team is working every day to improve technology and increase the safety and quality of laser vision correction.

The Zyoptix 217z100’s accuracy in treatment is such that over 90% of the patients that Dr. MacRae has treated with the Zyoptix 217z100 see 20/20 or better without their glasses after their primary treatment. The Zyoptix 217z100 is also an extremely safe laser. No one that Dr. MacRae has treated using this laser has lost more than two lines of best corrected vision. Patients treated with this laser also rarely complain of night vision symptoms such as glare, starburst and halos. We obtain these excellent results because of the large treatment zones and smooth treatment profiles created by the Zyoptix 217z100 when combined with Dr. MacRae’s approach of customizing treatment design for each individual.

Dr. MacRae and the StrongVision team are active participants in design and development of lasers like the Zyoptix 217z100. By having your refractive surgery at StrongVision, you are assured of access to the latest, most advanced technology available and the confidence in knowing that your doctor is working daily to make the technology safer and more precise.